Is Hologic Inc (HOLX) undervalued? · P/E 32, rev $4.10B
Hologic Inc (HOLX) is a medical instruments & supplies company listed on NASDAQ.
This page asks whether Hologic Inc (HOLX) looks cheap on cached numbers — not a DCF toy and not a buy alert.
Latest reported HOLX revenue for 2025-09-27 was $4.10B. Net income was $565.7M. Revenue was up 1.7% from 2024-09-28 to 2025-09-27. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
HOLX currently screens at market cap $16.97B and trailing P/E 31.5. Cheap versus history or peers still needs a filing reason; a low multiple can be a value trap.
A new HOLX 10-Q can flip this screen overnight. The SEC page is the source.
Not investment advice. Compare HOLX to the stock page model before you treat a low multiple as a gift.
Not investment advice.